| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |